Education
About Us
Working with TipRanks
Follow Us
RPG Life Sciences Limited (IN:RPGLIFE)
:RPGLIFE
Total Valuation
RPG Life Sciences Limited has a market cap or net worth of ₹39.44B. The enterprise value is ₹11.34B.
Market Cap₹39.44B
Enterprise Value₹11.34B
Share Statistics
RPG Life Sciences Limited has 16,539,015 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,539,015
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
RPG Life Sciences Limited’s return on equity (ROE) is 0.35 and return on invested capital (ROIC) is 45.82%.
Return on Equity (ROE)0.35
Return on Assets (ROA)0.28
Return on Invested Capital (ROIC)45.82%
Return on Capital Employed (ROCE)0.58
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.99
Inventory Turnover2.30
Valuation Ratios
The current PE Ratio of RPG Life Sciences Limited is 20.37. RPG Life Sciences Limited’s PEG ratio is 0.55.
PE Ratio20.37
PS Ratio0.00
PB Ratio3.77
Price to Fair Value7.03
Price to FCF19.94
Price to Operating Cash Flow12.76
PEG Ratio0.55
Income Statement
In the last 12 months, RPG Life Sciences Limited had revenue of 6.53B and earned 1.83B in profits. Earnings per share was 110.80.
Revenue6.53B
Gross Profit4.39B
Operating Income3.13B
Pretax Income2.33B
Net Income1.83B
EBITDA1.60B
Earnings Per Share (EPS)110.80
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
RPG Life Sciences Limited pays an annual dividend of ₹16, resulting in a dividend yield of 0.67%
Dividend Per Share₹16
Dividend Yield0.67%
Payout Ratio13.47%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.69
52-Week Price Change54.78%
50-Day Moving Average2.17K
200-Day Moving Average2.26K
Relative Strength Index (RSI)62.50
Average Volume (3m)1.76K
Important Dates
RPG Life Sciences Limited upcoming earnings date is Jul 31, 2025, TBA Not Confirmed.
Last Earnings DateApr 28, 2025
Next Earnings DateJul 31, 2025
Ex-Dividend DateJun 27, 2025
Financial Position
RPG Life Sciences Limited as a current ratio of 3.88, with Debt / Equity ratio of <0.01%
Current Ratio3.88
Quick Ratio3.11
Debt to Market Cap0.00
Net Debt to EBITDA-0.87
Interest Coverage Ratio0.00
Taxes
In the past 12 months, RPG Life Sciences Limited has paid 496.40M in taxes.
Income Tax496.40M
Effective Tax Rate0.21
Enterprise Valuation
RPG Life Sciences Limited EV to EBITDA ratio is 22.50, with an EV/FCF ratio of 85.88.
EV to Sales5.50
EV to EBITDA22.50
EV to Free Cash Flow85.88
EV to Operating Cash Flow46.14
Balance Sheet
RPG Life Sciences Limited has ₹2.66B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹2.66B billion.
Cash & Marketable Securities₹2.66B
Total Debt₹0.00
Net Cash-₹2.66B
Net Cash Per Share-₹160.54
Tangible Book Value Per Share₹307.03
Margins
Gross margin is 66.68%, with operating margin of 47.94%, and net profit margin of 28.04%.
Gross Margin66.68%
Operating Margin47.94%
Pretax Margin35.64%
Net Profit Margin28.04%
EBITDA Margin24.43%
EBIT Margin21.15%
Analyst Forecast
The average price target for RPG Life Sciences Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―